Hepatitis
- Oral Antiviral Therapy Uptake Low for HBV-Related Hepatocellular Carcinoma
- Adding Ribavirin to Combination Therapy for HCV Does Not Increase Cure Rate
- Acetaminophen Use Linked to Adverse Outcomes in Acute Hepatitis A
- Machine Learning Model Estimates HCC Risk for Antiviral Treatment in Chronic Hepatitis B
- Revaccination for HBV With Additional Doses Improves Response Rates in Cirrhosis
- Homelessness, Substance Use Increase Risk for Post-Treatment HCV Reinfection
- Rifaximin Linked to Reduced Infection Rate in Alcohol-Associated Hepatitis
- Point-of-Care HCV Testing Improves Treatment Uptake, Time to Initiation
- Hepatitis Outbreak Spurs Recall of Frozen Strawberries Sold at Costco, Trader Joe’s, Aldi
- CDC Updates Recommendations for Hepatitis B Virus Screening
- Hepatic Encephalopathy Associated With Dementia Onset in Veterans With Cirrhosis
- In Chronic Hepatitis B Infection, Tenofovir Withdrawal Is Not Recommended
Clinical Tools
Powered by
Powered by 
